4//SEC Filing
KERYX BIOPHARMACEUTICALS INC 4
Accession 0000899243-17-001440
CIK 0001114220operating
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:07 PM ET
Size
7.4 KB
Accession
0000899243-17-001440
Insider Transaction Report
Form 4
Carberry Christine A.
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-17+170,000→ 170,000 totalExercise: $6.02Exp: 2027-01-17→ Common Stock (170,000 underlying) - Award
Common Stock (Restricted)
2017-01-17+85,000→ 85,000 total
Footnotes (2)
- [F1]The 85,000 shares are restricted common stock, which will vest over three years with the first one-third vesting on January 17, 2018, and the remaining shares vesting in equal quarterly installments through the third anniversary of the grant date on January 17, 2020.
- [F2]The options vest according to the following schedule: the first one-third of the 170,000 options will vest on January 17, 2018, and the remaining options shall vest in equal quarterly installments through the third anniversary of the grant date on January 17, 2020.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001114220
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:07 PM ET
- Size
- 7.4 KB